H.R. 1672 · 118th Congress · House

Sickle Cell Disease Comprehensive Care Act

Active· Referred to the Subcommittee on Health.
Introduced
Mar 21, 23
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Sickle Cell Disease Comprehensive Care Act

This bill establishes and provides funds for a demonstration project for state Medicaid programs to improve outpatient care for individuals with sickle cell disease, with a focus on young adults and pregnant women.

The Centers for Medicare & Medicaid Services must award planning grants to at least 10 states and must select between 5 and 10 states to participate in the project. Participating states must provide specified services and support for individuals with sickle cell disease, including multidisciplinary care teams, appropriate treatments, mental health services, and specialist services.

The bill provides a 100% Federal Medical Assistance Percentage (i.e., federal matching rate) for services provided through the project.

Action Timeline

4
  1. MAR 31, 2023Committee

    Referred to the Subcommittee on Health.

  2. MAR 21, 2023IntroReferral

    Introduced in House

  3. MAR 21, 2023IntroReferral

    Introduced in House

  4. MAR 21, 2023IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Mar 31, 2023

Active

Energy and Commerce Committee

hsif00

Referred: Mar 21, 2023

Active